Danaher Corporation
DHR · Large Cap · NYSE · Healthcare · Diagnostics & Research
$226.12−$1.21 (-0.53%)
Opens in 53:35Next open: 9:30 AM ETFree AI brief
Get the full brief on DHR
Free to track. No card required. Usually ready in 10-15 minutes.
Where DHR sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$160.93
High$242.80
Today $226.12
RSI (14)
78.6Overbought
03070100
Stocksbrew score
56/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$195
Current price
$226.12
Median target
$230
Highest
$310
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Debt / equity
Favorable · 0.37 - strong leverage
0.53x
Current ratio
Strong · Good liquidity position
1.65x
⚠ Things to watch
Forward P/E
Needs attention · 17% above avg
25.37x
EV / EBITDA
Rich · Earnings can't support price
22.59x
ROIC
Weak · Weak capital efficiency
6.4%
ROE
Needs attention · Unfavorable
7.6%
How it stacks up against its peers
DHR against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $157.81B | 39.9 | +4.6% | 56 |
 | $10.01B | 19.1 | +19.7% | 78 |
 | $32.69B | 34.2 | +15.5% | 78 |
 | $4.23B | 12.7 | +13.5% | 78 |
 | $1.11T | 40.2 | +49.6% | 77 |